HTG2014-Section-Header-publications

Categories

Filter by Topics

ALK Apoptosis Asthma Autocrine Signaling B Cells benign Biofluid Biomarker Analysis Biomarker Discovery Biomarker Validation Biomarkers Bladder Cancer Breast Cancer Breast milk Cancer Genomics Cells Cerebrospinal Fluid Childhood Atopic Dermatitis Chronic Obstructive Pulmonary Disease Circulating miRNAs Colorectal cancer Comparative Study Comparison study computational toxicology Core Needle Biopsy COVID-19 Custom mRNA Cytokines Cytotoxic T Cells Dementia Diabetes Differential Expression Differential Gene Expression Analysis DLBCL Drug Response Drug Safety Drug Targets Drug-induced Liver Injury EGFR Muatations EMT epidemiology epigenomics Epstein-Barr Esophageal Cancer Exosomes Extracellular Vesicles Fabry Disease Feasibility FFPE FGF Ligand Trap Fibrous Tumors Gene Expression Profiling Gene Signature Analysis Glioblastoma Tumors Head and Neck Cancer Heart HTG EdgeSeq ALKPlus Assay EU HTG EdgeSeq Custom Assays HTG EdgeSeq DLBCL Cell of Origin Assay HTG EdgeSeq DLBCL-COO-CE-IVD HTG EdgeSeq Immune Response Panel HTG EdgeSeq Immuno-Oncology Assay HTG EdgeSeq miRNA Whole Transcriptome Assay HTG EdgeSeq miRNA Whole Transcriptome Panel HTG EdgeSeq Mouse mRNA Tumor Response Panel HTG EdgeSeq Oncology Biomarker Panel HTG EdgeSeq Path Assay HTG EdgeSeq Precision Immuno-Oncology Panel HTG EdgeSeq Precision Immunol-Oncology Panel HTG EdgeSeq System HTG EdgeSeq System Oncology Biomarker Panel HTG EdgSeq Immuno-Oncology Assay ibrutinib Immune Checkpoint Inhibitors Immune Related Genes Immune Response Immune Tolerance Immuno-Oncology immunohistochemistry IHC Immunotherapy Inflammation Juvenile Arthritis Kidney Liquid Biopsy Liver Lung Lung cancer Lymph Node Metastasis Lymphoma machine learning malignant Mechanism of Action Melanoma Mesothelioma Microenvironment MicroRNA miRNA Molecular Characterization Mouse mRNA custom mTOR pathway multi-omics Muscle Mutations NAFLD Nash and Fibrosis Neoantigens Neuroendocrine Tumor Neurologic Oncology Oral Cancer Osteoclast Ovarian cancer Pancreas Paralysis Pathogenesis Pathway analysis Pathway Analysis PCA Cell Lines PD-1 PD-L1 placenta Placenta Plasma predictive biology Predictive Biomarkers Predictive Modeling Progression free-survival Prostate Prostate Cancer qNPA Reproductive Response rate Reveal Rheumatoid Arthritis Risk Score Sarcoma Serum Signaling Inhibitors Signatures Sinonasal Carcinoma Skin SPECS Lung Consortium Squamous cell carcinoma Sub-typing surface plasmon Surveillance Survival Outcomes Synovial Fluid synthetic miRNA T-Cell T-cells Technology Comparison Therapeutic targets Thyroid Cancer TMB Toxicity Translational Medicine Treatment Outcome Tumor Biology Tumor Heterogeneity Tumor Microenvironment Urothelial carcinoma Uterus Wound healing Xenograft Tissue

2021

Circulating microRNA Breast Cancer Biomarker Detection in Patient Sera with Surface Plasmon Resonance Imaging Biosensor

Wong, C.L., et al., Circulating microRNA Breast Cancer Biomarker Detection in Patient Sera with Surface Plasmon Resonance Imaging Biosensor, Journal of BIOPhotonics, https://doi.org/10.1002/jbio.202100153

View External Link

Palociclib in combination with endocrine therapy versus capecitabine in hormonal receptor-positive, human epidermal growth factor 2-negative, aromatase

Martin, M., et al. Palociclib in combination with endocrine therapy versus capecitabine in hormonal receptor-positive, human epidermal growth factor 2-negative, aromatase. Annals of Oncology, Volume 32, Issue 4, April 2021, Pages 427-430

Download pdf 529KB

Gene expression comparison between primary estrogen receptor-positive and triple-negative breast cancer with paired axillary lymph node metastasis

Srour, M., et al. Gene expression comparison between primary estrogen receptor-positive and triple-negative breast cancer with paired axillary lymph node metastasis. Breast J. 2021 JAN 19. Jan 19. doi: 10.1111/tbj.14119. Online ahead of print

Download pdf 909KB

2020

Treatment effect of palbociclib plus endocrine therapy by prognostic and intrinsic subtype and biomarker analysis in patients with bone-only disease: a joint analysis of PALOMA-2 AND paloma-3 clinical trials

Finn, R., et al. Treatment effect of palbociclib plus endocrine therapy by prognostic and intrinsic subtype and biomarker analysis in patients with bone-only disease: a joint analysis of PALOMA-2 AND paloma-3 clinical trials. Breast Cancer Research and Treatment. 2020 AUG 11;  https://doi.org/10.1007/s10549-020-05782-4

Download pdf 773KB

Tumor mutational burden and immune infiltration as independent predictors of response to neoadjuvant immune checkpoint inhibition in early TNBC in GerparNuevo

Karn, T., et al. Tumor mutational burden and immune infiltration as independent predictors of response to neoadjuvant immune checkpoint inhibition in early TNBC in GerparNuevo. Annals of Oncology 2020 May 24; https://doi.org/10.1016/j.annonc.2020.05.015. In Press, Journal Pre-proof Online.

View External Link

Page last updated September 16, 2021